A new Clinical Series Bulletin has been published on the clinical section of the Tissuemed website. This latest report from surgeons at the Dept. of Neurosurgery, Bonn details use of TissuePatchDural for dura sealing in a patient with recurrent high grade glioma. In summary, the authors reported that ‘the use of TissuePatchDural provided efficient water tight closure of the dura. The postoperative course was uneventful and the patient recovered well. Daily routine wound inspections revealed no pathological findings’.
Tissuemed’s CEO, David Mandley noted, ‘this report details a positive clinical outcome following a potentially high risk surgery. We are pleased that patients continue to benefit from use of TissuePatchDural to prevent post-operative CSF leaks’.